Drug Type Non-degrading molecular glue |
Synonyms Domatinostat/Sirolimus, HLX-4310, VUJ 100 + [2] |
Target |
Action inhibitors |
Mechanism HDAC inhibitors(Histone deacetylase inhibitors), KDM1A inhibitors(Lysine-specific histone demethylase 1 inhibitors), mTOR inhibitors(Serine/threonine-protein kinase mTOR inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization |
Drug Highest PhaseIND Approval |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Osteosarcoma | IND Approval | United States | 01 Oct 2024 |





